Neuronetics, Inc. (STIM)
Last updated: 2026-10-20 19:54:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Neuronetics, Inc. (STIM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.99, with a market capitalization of $143.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.80 to $3.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$143.63M | |
$1.88 | |
$39.39 | |
$0.52 | |
$1.91 | |
509.79K | |
1.68M | |
-- | |
$3.44 | |
$0.80 | |
-- | |
-- |
Neuronetics, Inc. (STIM) Stock Price Today
Neuronetics, Inc. (STIM) is currently trading at $1.99 as of 2026-10-20 19:38:16, up 3.98% ($0.08) from the previous close of $1.91
During today's regular trading session, STIM has traded between $0.52 and $39.39, with a trading volume of 509.79K shares. The current price is near the lower end of today's range.
Neuronetics, Inc. (STIM) 7-Day Stock Price Change
Over the past seven days, Neuronetics, Inc. (STIM) moved from $2.13 to $1.99, representing a decline of 6.76% ($0.14).
The stock traded between $1.84 and $2.20 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 653.25 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
STIM 52-Week Price Position
Position in Range: 44.9%
STIM is currently trading at $1.99, placing it 44.9% of the way from its 52-week low of $0.80 to its 52-week high of $3.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Neuronetics, Inc. (STIM)?
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Neuronetics, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 658 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Neuronetics, Inc. (STIM) Stock on MEXC
Eligible investors can buy real shares of Neuronetics, Inc. (STIM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Neuronetics, Inc. (STIM) stock price today?
2.Is STIM stock going up or down today?
3.What is STIM pre-market price?
4.What is STIM after-hours price?
5.Is STIM stock trading now?
6.Where does STIM sit relative to its 52-week high and low?
7.What sector is Neuronetics, Inc. in?
8.What is Neuronetics, Inc.'s market capitalization and where is it listed?
9.How is STIM valued in terms of P/E ratio and EPS?
10.Does Neuronetics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
STIM Stock Calculator
Estimate the value between STIM shares and USD.
STIM Shares to USD
1.00 STIM shares = 1.986 USD
Calculations are estimates based on the latest available price and are for reference only.


